Key result
Apelin acts as both a peripheral adipokine and a hypothalamic neurotransmitter, playing a potential role in glucose metabolism and associated metabolic disorders such as obesity and type 2 diabetes.
This review summarizes the emerging role of the adipokine apelin in central and peripheral glucose homeostasis and its potential implications for metabolic disorders.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for apelin in obesity and type 2 diabetes; prospective trials needed before clinical consideration.
Hypothalamus is key area implicated in control of glucose homeostasis. This structure integrates nervous and peripheral informations to adapt a response modifying peripheral glucose utilization and maintaining energetic balance. Among peripheral signals, adipokines such as adiponectin and leptin are of special importance since deregulations of their actions are closely associated to metabolic disorders such as obesity and type 2 diabetes. During the past ten years, we have identified a new adipokine named apelin which has emerging role in the control of metabolism. The originality of the apelinergic system is to be largely represented in peripheral tissues (adipose tissue, intestine, etc.) and in the brain. Then, apelin is released by adipose tissue as all adipokines, but also present another crucial role as neurotransmitter in hypothalamic neurons. By acting in the whole body, apelin exerts pleiotropic actions and is now considered as a major determinant of physiological functions. Besides its general beneficial effects on peripheral targets, central action of apelin remains still a matter of debate. In this review, we have made a parallel between peripheral vs. central actions of apelin in term of signalization and effects. Then, we have focused our attention on hypothalamic apelin and its potential role in glucose metabolism and associated pathologies.
No takes yet. Share an insight, caveat, or question.
Knauf et al. (2013) conducted a review in Glucose homeostasis and metabolic disorders (obesity, type 2 diabetes). Apelin was evaluated. Apelin acts as both a peripheral adipokine and a hypothalamic neurotransmitter, playing a potential role in glucose metabolism and associated metabolic disorders such as obesity and type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: